Targeting the Plasmodium falciparum’s Thymidylate Monophosphate Kinase for the Identification of Novel Antimalarial Natural Compounds
Recent reports of resistance to artemisinin-based combination drugs necessitate the need to discover novel antimalarial compounds. The present study was aimed at identifying novel antimalarial compounds from natural product libraries using computational methods. Plasmodium falciparum is highly depen...
Gespeichert in:
Veröffentlicht in: | Frontiers in cellular and infection microbiology 2022-05, Vol.12, p.868529-868529 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Recent reports of resistance to artemisinin-based combination drugs necessitate the need to discover novel antimalarial compounds. The present study was aimed at identifying novel antimalarial compounds from natural product libraries using computational methods.
Plasmodium falciparum
is highly dependent on the pyrimidine biosynthetic pathway, a
de novo
pathway responsible for the production of pyrimidines, and the parasite lacks the pyrimidine salvage enzymes. The
P. falciparum
thymidylate monophosphate kinase (
Pf
TMPK) is an important protein necessary for rapid DNA replication; however, due to its broad substrate specificity, the protein is distinguished from its homologs, making it a suitable drug target. Compounds from AfroDB, a database of natural products originating from Africa, were screened virtually against
Pf
TMPK after filtering the compounds for absorption, distribution, metabolism, excretion, and toxicity (ADMET)-acceptable compounds with FAF-Drugs4. Thirteen hits with lower binding energies than thymidine monophosphate were selected after docking. Among the thirteen compounds, ZINC13374323 and ZINC13365918 with binding energies of −9.4 and −8.9 kcal/mol, respectively, were selected as plausible lead compounds because they exhibited structural properties that ensure proper binding at the active site and inhibitory effect against
Pf
TMPK. ZINC13374323 (also called aurantiamide acetate) is known to exhibit anti-inflammatory and antiviral activities, and ZINC13365918 exhibits antileishmanial activity. Furthermore, aurantiamide acetate, which is commercially available, is a constituent of
Artemisia annua
, the herb from which artemisinin was derived. The compound also shares interactions with several residues with a potent thymidine analog inhibitor of
Pf
TMPK. The anti-plasmodial activity of aurantiamide acetate was evaluated
in vitro
, and the mean half-maximal inhibitory concentration (IC
50
) was 69.33 μM when synchronized
P. falciparum
3D7 culture was used as compared to IC
50
> 100 μM with asynchronized culture. The significance of our findings within the context of malaria treatment strategies and challenges is discussed. |
---|---|
ISSN: | 2235-2988 2235-2988 |
DOI: | 10.3389/fcimb.2022.868529 |